Supernus Pharmaceuticals, Inc. · 6 hours ago
Senior Financial Analyst
Rockville, MD
Full-time
Onsite
Mid, Senior Level
$78K/yr - $90K/yr
4+ years expSupernus Pharmaceuticals, Inc. is a company focused on pharmaceutical development, and they are seeking a Senior Financial Analyst to support their corporate accounting and business functions. This role involves partnering with various departments to ensure accurate financial reporting, managing operational expenses, and assisting with budgeting and forecasting efforts.
BiotechnologyHealth CarePharmaceutical
No H1B
Responsibilities
Support and maintains business relationships with various department leads to provide business partnering and quality service from the Finance Department
Support, research, and understands the recording of monthly departmental transactions and activities, including relevant cash transactions
Support reconciliations of monthly business activity and agree the general ledger to the relevant source materials, including direct vendor verifications
Assists with the preparation of monthly and quarterly management reports of operational results
Responsible for the management of Departments’ operational expenses and projected spend
Works closely with various departments and Accounting to appropriately budget, forecast, and account for business activities
Provides support with annual budgeting/forecasting, financial account coding, purchase requisitions/purchase orders, and finance related questions
Performs monthly and quarterly accruals for supported departments and leads meetings to review vendor verifications, projected spend, and accrual data
Communicates with other departments and vendors as needed to ensure all invoices are processed and that all financial information is correct at the end of each month
Determine vouchered and unvouchered liabilities, assists with general ledger close, as well as support strategic vendor relationships
Assists the finance group and other key personnel with the Adaptive budgeting platform
Prepares schedules in support of internal and external auditor requests
Complies with and meets all financial close deadlines
Maintains compliance with SOX requirements, US Generally Accepted Accounting Principles (GAAP), and Company policies
Conducts other ad-hoc research, data analysis and department financial planning as defined by Management
Other Duties as Assigned
Qualification
Required
Bachelor's degree required, preferably in Accounting or Finance
A minimum of four years of relevant experience, or equivalent public accounting experience
Previous experience working with internal controls and procedures for financial reporting under SOX 404
Strong understanding of accounting principles including balance sheets and profit and loss statements
Proven ability to extract pertinent data from ERP systems or other sources
Excellent verbal and writing skills
Strong attention to detail and accuracy
Ability to work independently and as part of a team and maintain high ethical standards of integrity and quality
Ability of having an innovative and dynamic approach to work
A self-starter able to work independently but comfortable working in a team environment
Ability to consistently exhibit Supernus Values in interactions with employees at all levels of the organization, vendors, customers and others
Capable of performing other duties as assigned by Management
Authorized to legally work in the United States without visa sponsorship
Preferred
CPA preferred
Experience preferably within pharmaceutical or life science companies
Familiarity working with large data sets, Microsoft 365, adaptive insights, or equivalent systems
Benefits
Employee stock purchase programs
Performance-based bonus programs
Company
Supernus Pharmaceuticals, Inc.
We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$689.5MKey Investors
UBSNew Enterprise Associates
2023-02-14Post Ipo Debt· $150M
2018-03-13Post Ipo Debt· $350M
2013-04-24Post Ipo Debt· $90M
Leadership Team
J
Jack A. Khattar
President & CEO
F
Frank Mottola
Chief Technical Operations Officer
Recent News
Company data provided by crunchbase